טוען...
Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
OBJECTIVE: Compared with hemoglobin A1c (HbA1c), continuous glucose monitoring (CGM) may better capture risk of diabetes complications in patients with chronic kidney disease (CKD), including diabetic peripheral neuropathy (DPN). We hypothesized that glucose time in range (TIR), measured by CGM, is...
שמור ב:
| הוצא לאור ב: | BMJ Open Diabetes Res Care |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039577/ https://ncbi.nlm.nih.gov/pubmed/31958307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000991 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|